User Fees Would Fund Safety Oversight Throughout Product Life Cycles
This article was originally published in The Pink Sheet Daily
Executive Summary
PDUFA proposal expands scope of funding after FDA concludes that safety problems can occur well after a drug’s launch.
You may also be interested in...
Nearly Half Of User Fees Should Target Post-market Actions – FDA Draft Plan
Spending on various safety initiatives would remain stable over five years; final plan is due by year end.
Nearly Half Of User Fees Should Target Post-market Actions – FDA Draft Plan
Spending on various safety initiatives would remain stable over five years; final plan is due by year end.
FDA To Respond To IoM’s Rx Safety Recommendations
Commissioner von Eschenbach will detail how FDA plans to improve its oversight of drug risk issues.